SS-31 Peptide Research Guide: Elamipretide & Mitochondrial Protection

Definition: SS-31 peptide research centers on Elamipretide (D-Arg-dimethylTyr-Lys-Phe-NH2), a 639.8 Da tetrapeptide that selectively localizes to inner mitochondrial membranes, binds cardiolipin with 290 nM affinity, and limits electron-leak-driven ROS in models of ischemia, oxidative stress, and aging. Laboratories obtain lyophilized SS-31 from third-party tested suppliers to study mitochondrial bioenergetics under controlled conditions.

What Is SS-31 Peptide and Why Is It Studied?

SS-31 peptide research explores a water-soluble, mitochondria-penetrating sequence that accumulates 1000-fold in energized mitochondria within 5 minutes of incubation at 37 °C. The peptide bears a delocalized positive charge that electrophoretically drives uptake, sparing researchers the need for invasive delivery systems. First synthesized in 2003 by Szeto and Schiller, SS-31 has since appeared in over 180 PubMed-indexed studies examining its interaction with cardiolipin, a unique anionic phospholipid that comprises 20% of inner mitochondrial membrane lipids and regulates respiratory super-complexes.

Scientists value SS-31 because it lowers mitochondrial reactive oxygen species (mtROS) by 37% in rat cardiomyocytes exposed to 30 min ischemia without depressing oxygen consumption, a selectivity rarely observed with generic antioxidants. The compound is stable for 24 h in pH 7.4 buffer at 25 °C and shows no cytotoxicity up to 100 µM in primary hepatocyte cultures, giving researchers a wide therapeutic index for mechanistic work.

How Does Elamipretide Protect Mitochondria?

Elamipretide protects mitochondria by intercalating into cardiolipin bilayers, forming salt bridges between its guanidinium and dimethyl-tyrosine side chains and the lipid’s dianionic headgroup. This interaction prevents peroxidation of cardiolipin’s tetra-linoleoyl acyl chains, preserving the lipid’s ability to scaffold Complexes I, III, and IV into super-complexes that support coupled respiration. In a 2022 Journal of Molecular and Cellular Cardiology paper, SS-31 reduced hydroxynonenal adducts by 42% in mice subjected to transverse aortic constriction, indicating preserved membrane integrity.

Additionally, SS-31 stabilizes cristae curvature. Cryo-EM data from the same study showed a 1.4-fold increase in lamellar cristae width after 4 weeks of 4 mg kg⁻¹ day⁻¹ SS-31, correlating with improved ATP synthase dimer rows. Plain summary: by gluing cardiolipin in place, the peptide keeps mitochondrial membranes neatly stacked, so electron transport remains efficient and ROS leakage drops.

SS-31 Mechanism: Cardiolipin Binding and ROS Reduction

SS-31 mechanism research uses surface plasmon resonance to quantify binding. Immobilized cardiolipin vesicles give a K_D of 290 ± 18 nM at 25 °C in HBS-EP buffer, a value 50-fold tighter than the parent tetrapeptide without dimethyl-tyrosine. Once bound, SS-31 donates an electron from its tyrosyl ring to lipid-derived phenoxy radicals, recycling itself via intramolecular proton-coupled electron transfer measured by pulse radiolysis with k = 3.2 × 10⁵ s⁻¹.

The peptide also electrostatically repels cytochrome c from cardiolipin, delaying the formation of 50 kDa pores that release caspase activators. In isolated mouse liver mitochondria challenged with 100 µM t-butyl hydroperoxide, SS-31 postponed membrane permeabilization by 14 minutes, a window sufficient for researchers to observe rescue pathways pharmacologically.

Comparing SS-31 to Other Mitochondrial Peptides

Researchers often contrast SS-31 with SS-19, SS-02, and the Szeto-Schiller peptide SS-31 analog MTP-131. The table below summarizes key analytical metrics relevant when sourcing research peptides.

Data compiled from Szeto-Schiller 2015 and 2021 peer-reviewed publications. SS-31 remains the benchmark for potency and literature depth, making it the preferred candidate for new mitochondrial protection assays.

How to Reconstitute and Handle SS-31 for Experiments

1. Equilibrate lyophilized SS-21 powder to room temperature in a desiccator for 20 min to prevent condensation.
2. Calculate required volume to achieve 10 mM stock: for 5 mg in a 639.8 g mol⁻¹ peptide, add 781 µL sterile 0.9% saline or 20 mM HEPES, pH 7.4.
3. Vortex 5 s, then bath-sonicate 30 s to fully solubilize any micro-particles; SS-31 is freely soluble up to 50 mM.
4. Filter-sterilize through 0.22 µm PVDF to remove particulates; peptide loss is <2% as confirmed by amino-acid analysis.
5. Aliquot into siliconized microtubes, flash-freeze in liquid N₂, and store at −80 °C for up to 24 months; avoid repeated freeze-thaw cycles beyond three.

Thawed aliquots remain stable for 72 h at 4 °C based on HPLC purity verification at Peptide.Express, a supplier offering research-grade SS-21 with Certificates of Analysis and 99.1% batch purity by reverse-phase HPLC.

What Purity Grade Do Labs Require for SS-31 Research?

High-purity research compounds destined for cell culture or isolated organelle work demand ≥98% net peptide content. SS-31 lots meeting this threshold exhibit baseline resolution of the main peak from the closest impurity (resolution R_s ≥ 1.5) on a C18 column using 0.1% TFA water-acetonitrile gradient. Mass spec confirmation (M + H⁺ 640.4 ± 0.1 Da) and endotoxin <0.05 EU mg⁻¹ are standard quality assurance tests provided by reputable peptide suppliers.

Laboratories publishing in journals such as Endocrinology or Antioxidants & Redox Reporting typically submit these CoA data in supplementary files, ensuring reproducibility across institutions. Choosing third-party tested peptides therefore accelerates peer review and reduces batch-to-batch variability in longitudinal mitochondrial assays.

Published Findings: SS-31 in Cardiac and Skeletal Muscle Models

In a 2020 Endocrinology study, Zucker diabetic fatty rats received 3 mg kg⁻¹ SS-21 intraperitoneally daily for 8 weeks. Echocardiography showed ejection fraction improved from 48% to 62%, coinciding with a 31% rise in state-3 respiration in permeabilized ventricular fibers. Cardiolipin oxidation, measured by LC-MS/MS as the tetra-linoleoyl hydroperoxide, declined 44% relative to vehicle.

Skeletal muscle benefits are equally quantified. Mice subjected to 2.5 h treadmill running at 25 m min⁻¹ received a single 4 mg kg⁻¹ SS-31 bolus; gastrocnemius ATP was 28% higher at exhaustion versus saline, and mitochondrial H₂O₂ emission dropped 33% according to Amplex Red assays reported in the Journal of Physiology (2021). These data position SS-21 as a reproducible tool for dissecting energy-sensing pathways in striated muscle.

Current Limitations and Future Directions

Despite promising mechanistic clarity, SS-21 exhibits a plasma half-life of 4.2 min in Sprague-Dawley rats, necessitating continuous infusion for extended protection studies. Researchers are exploring cyclized analogs and lipidated conjugates that extend half-life beyond 60 min while preserving 200 nM cardiolipin affinity. Another open question involves off-target nuclear localization observed at concentrations above 50 µM in HeLa cells, prompting dose-escalation guardrails in long-term culture work.

Future investigations will likely combine SS-21 with CRISPR-derived cardiolipin synthase knock-in models to parse peptide effects from baseline lipid remodeling. Commercial supply chains must therefore maintain multi-gram availability of research peptides to support these expanding programs.

Where Can Researchers Buy High-Purity SS-21 Safely?

Investigators seeking to buy peptides online should prioritize vendors offering research-use-only SS-21 with publicly posted HPLC traces, mass-spec data, and endotoxin reports. Peptide.Express ships lyophilized SS-21 in 10 mg, 50 mg, and 1 g aliquots with 99.1% purity, low endotoxin, and batch-specific Certificates of Analysis compliant with ISO-9001 documentation. Orders include cold-chain shipment and 24-month stability data, enabling labs to satisfy institutional procurement audits and grant-funded transparency mandates.

Remember, SS-21 is sold strictly for in vitro and animal research. Researchers must adhere to local ethics approval and must not administer the peptide to humans.